We offer an economical alternative for these Companies by providing the expertise needed to assess the market dynamics for their technologies and the creation of comprehensive marketing strategies designed to drive revenue growth.
Portsmouth, NH (PRWEB) September 22, 2009
The Atticus Group, LLC, a privately held company, announced today the establishment of its marketing consulting service for medical technology companies. Through this service the Company will provide both strategic planning and tactical marketing support to companies who are developing and commercializing novel medical technologies.
"Many companies with innovative new medical technologies are currently faced with the difficulty of managing both people and financial resources as they begin product commercialization efforts," stated Larry Yost, Managing Partner of the Atticus Group. "We offer an economical alternative for these Companies by providing the expertise needed to assess the market dynamics for their technologies and the creation of comprehensive marketing strategies designed to drive revenue growth."
Services the Atticus Group offers include the assessment of the clinical value, market potential and competitive advantage for new medical technologies, the development of in-depth strategic marketing plans, as well as the development and implementation of clinical strategies which support product commercialization efforts. The Company also has the capability to create and develop marketing collateral which support tactical sales activities.
With experience across a wide range of medical and surgical markets, The Atticus Group is currently providing strategic marketing consultative services to both U.S. and foreign-based technology companies who are commercializing novel medical technologies in the U.S. and select global markets.
About The Atticus Group, LLC:
The Atticus Group's mission is to partner with medical technology companies to develop strategic marketing plans and tactical marketing initiatives which drive revenue growth helping them to achieve business objectives. The Atticus Group's primary focus is towards companies which have novel medical technologies being commercialized in the U.S. and select global markets. The Company also conducts technology due-diligence assessments for venture capital groups. The Atticus Group was founded by Larry Yost who has over 25 years of domestic and international medical device and pharmaceutical company experience.
For more information on The Atticus Group, visit our website at http://www.theatticusgroup.net.
The Atticus Group, LLC
P.O. Box 455
Portsmouth, NH 03802-0455